EV/EBITDA
-3.58
+0.20+5.29%
9 min ago
Summary:
Sangamo Therapeutics EV/EBITDA is currently -3.58, with a rise of +0.20 (+5.29%) during the most recent trading day. Over the past year, it has dropped by -2.98 (-496.67%). SGMO EV/EBITDA is now -1332.00% below its all-time high of -0.25.SGMO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +5.3% |
| 1 m1 month | -9.5% |
| 3 m3 months | -293.4% |
| 6 m6 months | -752.4% |
| ytdytd | -265.3% |
| 1 y1 year | -496.7% |
| 5 y5 years | +63.5% |
SGMO EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -2.52 | -42.1% | -4.96 | +27.8% |
| 3 m | 3 months | -0.79 | -353.2% | -4.96 | +27.8% |
| 6 m | 6 months | -0.25 | -1332.0% | -4.96 | +27.8% |
| 1 y | 1 year | -0.25 | -1332.0% | -4.96 | +27.8% |
| 3 y | 3 years | -0.25 | -1332.0% | -6.63 | +46.0% |
| 5 y | 5 years | -0.25 | -1332.0% | -32.70 | +89.0% |
| alltime | all time | -0.25 | -1332.0% | -310.86 | +98.8% |
Sangamo Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -3.58(+265.3%) |
| 2023 | -0.98(-62.9%) |
| 2022 | -2.64(-54.6%) |
| 2021 | -5.82(-68.2%) |
| 2020 | -18.32(+87.3%) |
| 2019 | -9.78(-31.0%) |
| 2018 | -14.18(-43.6%) |
| 2017 | -25.13(+807.2%) |
| 2016 | -2.77(-77.8%) |
| 2015 | -12.49(-68.6%) |
| 2014 | -39.81(+21.8%) |
| 2013 | -32.69(+136.9%) |
| Date | Value |
|---|---|
| 2012 | -13.80(+266.0%) |
| 2011 | -3.77(-68.5%) |
| 2010 | -11.98(-8.0%) |
| 2009 | -13.02(+162.5%) |
| 2008 | -4.96(-77.1%) |
| 2007 | -21.67(+105.2%) |
| 2006 | -10.56(+33.7%) |
| 2005 | -7.90(-64.8%) |
| 2004 | -22.43(+69.4%) |
| 2003 | -13.24(+549.0%) |
| 2002 | -2.04(-91.0%) |
| 2001 | -22.55(-61.2%) |
| 2000 | -58.16 |
FAQ
- What is Sangamo Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Sangamo Therapeutics?
- What is SGMO EV/EBITDA year-to-date change?
- What is Sangamo Therapeutics EV/EBITDA year-on-year change?
What is Sangamo Therapeutics EV/EBITDA?
The current EV/EBITDA of SGMO is -3.58
What is the all time high EV/EBITDA for Sangamo Therapeutics?
Sangamo Therapeutics all-time high EV/EBITDA is -0.25
What is SGMO EV/EBITDA year-to-date change?
Sangamo Therapeutics EV/EBITDA has changed by -2.60 (-265.31%) since the beginning of the year
What is Sangamo Therapeutics EV/EBITDA year-on-year change?
Over the past year, SGMO EV/EBITDA has changed by -2.98 (-496.67%)